JMIR Diabetes

Emerging technologies, medical devices, apps, sensors, and informatics to help people with diabetes

Editor-in-Chief:

Ricardo Correa, MD, EdD (Co-Editor-in-Chief), Cleveland Clinic, United States

Sheyu Li, MD (Co-Editor-in-Chief), West China Hospital, Sichuan University, China


Impact Factor 2.6 CiteScore 4.7

JMIR Diabetes (JD, ISSN 2371-4379) focuses on technologies, medical devices, apps, engineering, informatics and patient education for diabetes prevention, self-management, care, and cure, to help people with diabetes. JMIR Diabetes may consider papers that do not have a digital health component but represent a significant innovation for diabetes prevention and care.

JMIR Diabetes publishes original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews) covering, for example, wearable devices and trackers, mobile apps, glucose monitoring (including emerging technologies such as Google contact lens), medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and "quantified self", diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes.

As an Open Access journal, JMIR Diabetes is read by clinicians and patients alike and has (as all JMIR Publications journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies, as well as on diabetes prevention and epidemiology.

JMIR Diabetes is indexed in PubMed, PubMed Central, DOAJ, Scopus and the Web of Science™ (ESCI).

JMIR Diabetes received an inaugural Journal Impact Factor of 2.6 according to the latest release of the Journal Citation Reports from Clarivate, 2025.

With a CiteScore of 4.7 (2024), JMIR Diabetes is a Q2 journal in the field of Health Informatiion Management, according to Scopus data.

 

 

Recent Articles

Article Thumbnail
Glucose Tracking and Self-Monitoring of Blood Glucose

Exercise is an important aspect of diabetes self-management. Patients with type 1 diabetes frequently struggle with exercise-induced hyperglycemia and hypoglycemia, decreasing their willingness to exercise. Objective: We aim to build accurate and easy-to-deploy models to forecast exercise-induced glycemic events in real-world settings.

|
Article Thumbnail
Apps, Mobile, Wearables for Diabetes

Chinese Americans with type 2 diabetes (T2D) face significant challenges in dietary management, which is crucial for glycemic control. Wearable sensors, such as the eButton and continuous glucose monitor (CGM), offer a promising solution.

|
Article Thumbnail
Diabetes Self-Management

The COVID-19 pandemic led to increased patient demand for remote management of type 2 diabetes using secure messaging, or patient-provider text-based communication. Prior research on secure messaging has described the content of messages sent for type 2 diabetes management and demonstrated its impact on clinical outcomes. However, there is a gap in knowledge about how secure messaging performs as a communication medium for specific tasks in clinical care (e.g. prescription management, discussing medical questions). Additional research is needed to understand physician experiences using secure messaging to communicate with patients about clinical tasks that support diabetes management.

|
Article Thumbnail
Artificial Intelligence in Diabetes Care and Prevention

Clinicians currently lack an effective means for identifying youth with type 1 diabetes (T1D) who are at risk for experiencing glycemic deterioration between diabetes clinic visits. As a result, their ability to identify youth who may optimally benefit from targeted interventions designed to address rising glycemic levels is limited. Although electronic health records (EHR)-based risk predictions have been used to forecast health outcomes in T1D, no study has investigated the potential for using EHR data to identify youth with T1D who will experience a clinically significant rise in HbA1c ≥0.3% (~3 mmol/mol) between diabetes clinic visits.

|
Article Thumbnail
Diabetes Technology Around the World

The COVID-19 pandemic catalyzed the adoption of digital technologies in health care. This study assesses a digital-first integrated care model for type 2 diabetes management in Western Sydney, using continuous glucose monitoring (CGM) and virtual Diabetes Case Conferences (DCC) involving the patient, general practitioner (GP), diabetes specialist, and diabetes educator at the same time.

|
Article Thumbnail
Diabetes Health Services and System Innovations

Inequity in diabetes technology use persists among Black and Hispanic youth with type 1 diabetes (T1D). Community health workers (CHWs) can address social and clinical barriers to diabetes device use. However, more information is needed on clinicians’ perceptions to inform the development of a CHW model for youth with T1D.

|
Article Thumbnail
Apps, Mobile, Wearables for Diabetes

Type 2 diabetes (T2D) is a complex, chronic condition that requires ongoing management. An important aspect of effective diabetes management is shared decision-making between the person with diabetes and the healthcare professionals (HCPs) to tailor individual treatment plans. Personal health technologies can play a crucial role in this collaborative effort by providing tools for monitoring, communication, and education.

|
Article Thumbnail
Apps, Mobile, Wearables for Diabetes

A novel mobile health (mHealth) App “acT1ve”, developed using a co-design model provides real-time support during exercise for young people with type 1 diabetes (T1D).

|
Article Thumbnail
Apps, Mobile, Wearables for Diabetes

Diabetes mellitus (DM) is a chronic condition requiring effective self-management to maintain glycemic control and prevent complications. Mobile health (mHealth) apps offer potential solutions by providing real-time monitoring, personalized feedback, and educational resources. However, their long-term adoption is hindered by a lack of user involvement in the development process and insufficient cultural adaptation. This study aims to explore the perspectives of DM patients in Hong Kong on the functionalities and features of mHealth apps, highlighting the importance of tailoring these apps to meet local cultural needs.

|
Article Thumbnail
Apps, Mobile, Wearables for Diabetes

Gestational Diabetes Mellitus (GDM), a type of blood glucose intolerance or hyperglycaemia that occurs during pregnancy, is a common condition increasing in prevalence both globally and in Australia. Mobile health applications have been shown as a useful resource for women with Type 1 diabetes and could successfully contribute to GDM management by facilitating healthy behaviours.

|

Preprints Open for Peer-Review

We are working in partnership with